Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitomycin: clinical applications in ophthalmic practice.

Lekha M Abraham1, Dinesh Selva, Robert Casson

  • 1Department of Ophthalmology and Visual Sciences, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia.

Drugs
|March 11, 2006
PubMed
Summary

Mitomycin C (MMC), an antibiotic, effectively inhibits wound healing and scarring in ophthalmic surgeries. This bioreductive agent shows significant benefits in treating various eye conditions and surgical procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraorbital and intracranial extension of adenoid cystic carcinoma without clinical or radiological lacrimal gland involvement.

Orbit (Amsterdam, Netherlands)·2021
Same author

Granuloma Faciale Involving the Tarsoconjunctival Surface of the Eyelid.

Ophthalmic plastic and reconstructive surgery·2021
Same author

Non-infectious Dacryoadenitis.

Survey of ophthalmology·2021
Same author

Medial Canthal Contraction as a Marker for Orbital Invasion in Basal Cell Carcinoma.

Ophthalmic plastic and reconstructive surgery·2021
Same author

Cerebrospinal Fluid Leak Presenting as a Subperiosteal Collection.

Ophthalmic plastic and reconstructive surgery·2021
Same author

Canthoplasty repair for canthal rounding.

Eye (London, England)·2021

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Oncology

Background:

  • Mitomycin C (MMC) is an antibiotic derived from Streptomyces caespitosus.
  • It functions as a bioreductive alkylating agent with oxygen tension-dependent cytotoxic effects, including DNA cross-linking.

Purpose of the Study:

  • To review the established and emerging applications of topical Mitomycin C in ophthalmic and adnexal surgery.
  • To highlight its efficacy in managing wound healing and scarring post-surgery.

Main Methods:

  • Literature review of studies investigating Mitomycin C's use in ocular and adnexal surgeries.
  • Analysis of its mechanism of action and clinical outcomes in various ophthalmic pathologies.

Main Results:

Related Experiment Videos

  • Mitomycin C is widely used to inhibit wound healing and reduce scarring in ophthalmic procedures.
  • It has demonstrated significant beneficial effects as adjunctive therapy in glaucoma filtering surgeries, dacryocystorhinostomy, corneal refractive surgery, and pterygium excision.
  • Its utility extends to managing ocular surface squamous neoplasia, primary acquired melanosis with atypia, and conjunctival melanoma.

    • Conclusions:

    • Mitomycin C is a valuable adjunctive agent in a broad spectrum of ophthalmic surgeries.
    • Its antifibrotic and cytotoxic properties contribute to improved surgical outcomes and reduced complications.